Invention Grant
- Patent Title: Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9
-
Application No.: US14100992Application Date: 2013-12-09
-
Publication No.: US09724411B2Publication Date: 2017-08-08
- Inventor: Mark W. Sleeman , Joel H. Martin , Tammy T. Huang , Douglas MacDonald , Gary Swergold , Robert C. Pordy , William J. Sasiela
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Swanson & Bratschun, L.L.C.
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/40 ; A61K31/40 ; A61K39/00
Abstract:
The present invention provides methods for treating hypercholesterolemia and reducing LDL-C. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an anti-PCSK9 antibody or antigen-binding fragment thereof.
Public/Granted literature
- US20140099312A1 Methods for Treating Hypercholesterolemia and Reducing LDL-C Using Antibodies to PCSK9 Public/Granted day:2014-04-10
Information query
